Terms: = Lymphoma AND IGL AND Diagnosis
38 results:
1. Assessment of Clonotypic Rearrangements and Minimal Residual Disease in Lymphoid Malignancies.
Hussaini MO; Srivastava J; Lee LW; Nishihori T; Shah BD; Alsina M; Pinilla-Ibarz J; Shain KH
Arch Pathol Lab Med; 2022 Apr; 146(4):485-493. PubMed ID: 34343238
[TBL] [Abstract] [Full Text] [Related]
2. Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features.
Aukema SM; Croci GA; Bens S; Oehl-Huber K; Wagener R; Ott G; Rosenwald A; Kluin PM; van den Berg E; Bosga-Bouwer AG; Hoogendoorn M; Hoster E; Bittmann I; Nagel I; Murga Penas EM; Kreuz M; Bausinger J; Belder W; Oschlies I; Dyer MJS; Jayne S; Siebert R; Klapper W
Virchows Arch; 2021 Jul; 479(1):133-145. PubMed ID: 33528622
[TBL] [Abstract] [Full Text] [Related]
3. The association of gene rearrangement and lymphoma diagnosis: A prospective observational study.
He X; Xu P; Wang X; Jiang S; Gong D; Wu N
Medicine (Baltimore); 2020 Jun; 99(24):e20733. PubMed ID: 32541525
[TBL] [Abstract] [Full Text] [Related]
4. Colorectal diffuse large B-cell lymphoma: molecular subclassification and prognostic significance of immunoglobulin gene translocation.
Hori Y; Yamamoto H; Nozaki Y; Torisu T; Fujiwara M; Taguchi K; Nishiyama K; Nakamura S; Kitazono T; Oda Y
Hum Pathol; 2020 Feb; 96():67-78. PubMed ID: 31734190
[TBL] [Abstract] [Full Text] [Related]
5. Contribution of immunoglobulin lambda light chain gene rearrangement analysis in the diagnosis of B-cell neoplasms.
Paterson AL; El-Daly H; Raso-Barnett L; Du MQ; Giger O; Soilleux E; Roberts T; Huang Y; Bibawi H; Matharu B; Bench A; Scott MA; Liu H
Br J Haematol; 2019 Apr; 185(2):261-265. PubMed ID: 30681735
[TBL] [Abstract] [Full Text] [Related]
6.
Martín-Garcia D; Navarro A; Valdés-Mas R; Clot G; Gutiérrez-Abril J; Prieto M; Ribera-Cortada I; Woroniecka R; Rymkiewicz G; Bens S; de Leval L; Rosenwald A; Ferry JA; Hsi ED; Fu K; Delabie J; Weisenburger D; de Jong D; Climent F; O'Connor SJ; Swerdlow SH; Torrents D; Beltran S; Espinet B; González-Farré B; Veloza L; Costa D; Matutes E; Siebert R; Ott G; Quintanilla-Martinez L; Jaffe ES; López-Otín C; Salaverria I; Puente XS; Campo E; Beà S
Blood; 2019 Feb; 133(9):940-951. PubMed ID: 30538135
[TBL] [Abstract] [Full Text] [Related]
7. Primary Cutaneous Follicle Center lymphomas Expressing BCL2 Protein Frequently Harbor BCL2 Gene Break and May Present 1p36 Deletion: A Study of 20 Cases.
Szablewski V; Ingen-Housz-Oro S; Baia M; Delfau-Larue MH; Copie-Bergman C; Ortonne N
Am J Surg Pathol; 2016 Jan; 40(1):127-36. PubMed ID: 26658664
[TBL] [Abstract] [Full Text] [Related]
8. A look into the evolution of Epstein-Barr virus-induced lymphoproliferative disorders: a case study.
Ambrosio MR; Rocca BJ; Ginori A; Mourmouras V; Amato T; Vindigni C; Lazzi S; Leoncini L
Am J Clin Pathol; 2015 Nov; 144(5):817-22. PubMed ID: 26486748
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of IGK and igl molecular gene rearrangements according to the BIOMED-2 protocols for clinical diagnosis of Hodgkin lymphoma.
Ghorbian S; Jahanzad I; Javadi GR; Sakhinia E
Hematology; 2016 Apr; 21(3):133-7. PubMed ID: 26183240
[TBL] [Abstract] [Full Text] [Related]
10. Invivoscribe BIOMED-2 primer mixes in B-cell immunoglobulin gene rearrangement studies: experience of a molecular diagnostics laboratory in a major tertiary care center.
Abbas F; Yazbek SN; Shammaa D; Hoteit R; Fermanian P; Mahfouz R
Genet Test Mol Biomarkers; 2014 Dec; 18(12):787-90. PubMed ID: 25299065
[TBL] [Abstract] [Full Text] [Related]
11. Nodal involvement by marginal zone B-cell lymphoma harboring t(14;22)(q32;q11) involving immunoglobulin heavy chain and light chain lambda as the sole karyotypically recognizable abnormality in a patient with systemic lupus erythematosus.
Li K; Johnson RL; Li S; Thorson JA; Mulroney CM; Dell'Aquila ML; Wang HY
Int J Clin Exp Pathol; 2014; 7(8):5221-31. PubMed ID: 25197401
[TBL] [Abstract] [Full Text] [Related]
12. Diagnostic challenges in a case of B cell lymphoma unclassifiable with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.
So CC; Yung KH; Chu ML; Wan TS
Int J Hematol; 2013 Oct; 98(4):478-82. PubMed ID: 23959583
[TBL] [Abstract] [Full Text] [Related]
13. [Study of immunoglobulin and T-cell receptor gene rearrangements in patients with non-Hodgkin's lymphoma].
Wu RQ; Qiao C; Tong Y; Ge Z; Zhang JF; Wu YJ; Qiu HR; Wang Z; Liu P
Zhonghua Xue Ye Xue Za Zhi; 2012 Jan; 33(1):10-5. PubMed ID: 22575185
[TBL] [Abstract] [Full Text] [Related]
14. Histopathologic and immunohistochemical features of Hashimoto thyroiditis.
Amani HK
Indian J Pathol Microbiol; 2011; 54(3):464-71. PubMed ID: 21934204
[TBL] [Abstract] [Full Text] [Related]
15. BCL2 and MYC dual-hit lymphoma/leukemia.
Tomita N
J Clin Exp Hematop; 2011; 51(1):7-12. PubMed ID: 21628855
[TBL] [Abstract] [Full Text] [Related]
16. Primary high-grade B-cell lymphoma of the breast with concurrent IGH-BCL2 and MYC-igl translocations in an adolescent patient.
Liang X; Jones A; Giller RH; Swisshelm K; McGavran L; Meltesen L; Carstens B; McGranahan AN; Albano EA
Pediatr Dev Pathol; 2011; 14(5):402-6. PubMed ID: 21491965
[TBL] [Abstract] [Full Text] [Related]
17. [Immunoglobulin heavy chain gene rearrangement study in difficult cases of B-cell lymphoproliferative disorder].
Wang Q; Li XQ; Zhu XZ; Zhu XL; Lu HF; Zhang TM; Zhou XY
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):296-301. PubMed ID: 20654151
[TBL] [Abstract] [Full Text] [Related]
18. Primary cutaneous marginal zone B-cell lymphoma with amyloid deposition: report of two cases with review of literature.
Zhang HY; Liu AL; Zhou LS; He MX; Wang JX
Chin J Cancer; 2010 Jun; 29(6):634-40. PubMed ID: 20507739
[TBL] [Abstract] [Full Text] [Related]
19. [Solitary plasmacytoma of bone: a clinicopathologic, immunohistochemical and immunoglobulin gene rearrangement study].
Zuo Z; Liu WP; Tang Y; Bi CF; Wang XQ; Zhang WY; Yang QP; Zou LQ
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):177-82. PubMed ID: 20450765
[TBL] [Abstract] [Full Text] [Related]
20. Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations.
Tomita N; Tokunaka M; Nakamura N; Takeuchi K; Koike J; Motomura S; Miyamoto K; Kikuchi A; Hyo R; Yakushijin Y; Masaki Y; Fujii S; Hayashi T; Ishigatsubo Y; Miura I
Haematologica; 2009 Jul; 94(7):935-43. PubMed ID: 19535347
[TBL] [Abstract] [Full Text] [Related]
[Next]
